A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

Clinical trial NCT01599234 · COMPLETED

Trial details

NCT number: NCT01599234
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2005-03-01
Primary completion: 2005-12-01
Enrollment: 337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.